RYTM · Healthcare · $6.5B
$94.35+1.01%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출 7,100만 달러 — 전 분기 대비 19% 늘며 5,100만→5,700만→6,000만→7,100만 달러로 이어진 가속 흐름의 정점이에요.”
In the company's words · 2026 2분기 earnings call